Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,860.00
+105.00 (2.21%)
At close: Jun 4, 2026
Cellromax Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Cash & Equivalents | 3,213 | 678.33 | 1,054 |
Short-Term Investments | 2,015 | 2,020 | 14,767 |
Trading Asset Securities | 4,035 | 5,005 | 6,910 |
Cash & Short-Term Investments | 9,263 | 7,703 | 22,732 |
Cash Growth | -47.16% | -66.11% | - |
Accounts Receivable | 908.98 | 723.54 | 531.1 |
Other Receivables | 208.6 | 93.05 | 110.04 |
Receivables | 1,118 | 816.59 | 641.14 |
Inventory | 5,145 | 5,684 | 5,186 |
Prepaid Expenses | 78.35 | 56.6 | 38.07 |
Other Current Assets | 139.19 | 120.8 | 105.36 |
Total Current Assets | 15,744 | 14,382 | 28,702 |
Property, Plant & Equipment | 3,378 | 3,509 | 3,661 |
Long-Term Investments | 29,164 | 29,184 | 10,719 |
Other Intangible Assets | 2,798 | 2,801 | 3,470 |
Long-Term Accounts Receivable | 0 | 0 | -0 |
Long-Term Deferred Tax Assets | - | - | 68.46 |
Other Long-Term Assets | 940.89 | 1,032 | 2,479 |
Total Assets | 52,025 | 50,908 | 49,100 |
Accounts Payable | 988.51 | 1,609 | 1,543 |
Accrued Expenses | 725.5 | 494.9 | 426.72 |
Current Portion of Leases | 171.62 | 209.8 | 166.9 |
Current Income Taxes Payable | 313.67 | 22.92 | 562.08 |
Other Current Liabilities | 1,035 | 427.46 | 456.07 |
Total Current Liabilities | 3,235 | 2,764 | 3,154 |
Long-Term Debt | - | - | 983.07 |
Long-Term Leases | 212.39 | 268.03 | 348.21 |
Pension & Post-Retirement Benefits | 0.62 | 8.34 | 93.05 |
Long-Term Deferred Tax Liabilities | 949.58 | 949.58 | - |
Other Long-Term Liabilities | 0 | - | -0 |
Total Liabilities | 4,397 | 3,990 | 4,579 |
Common Stock | 1,177 | 1,177 | 1,164 |
Additional Paid-In Capital | 7,050 | 7,050 | 13,152 |
Retained Earnings | 36,960 | 38,211 | 32,875 |
Treasury Stock | -934.19 | -2,818 | -2,670 |
Comprehensive Income & Other | 3,375 | 3,299 | -0 |
Shareholders' Equity | 47,628 | 46,918 | 44,522 |
Total Liabilities & Equity | 52,025 | 50,908 | 49,100 |
Total Debt | 384.01 | 477.83 | 1,498 |
Net Cash (Debt) | 8,879 | 7,226 | 21,234 |
Net Cash Growth | -44.10% | -65.97% | - |
Net Cash Per Share | 781.73 | 633.29 | 2041.44 |
Filing Date Shares Outstanding | 11.34 | 11.16 | 11.36 |
Total Common Shares Outstanding | 11.34 | 11.16 | 11.36 |
Working Capital | 12,509 | 11,618 | 25,548 |
Book Value Per Share | 4198.96 | 4202.28 | 3920.63 |
Tangible Book Value | 44,830 | 44,117 | 41,051 |
Tangible Book Value Per Share | 3952.28 | 3951.39 | 3615.03 |
Land | - | 996.84 | 996.84 |
Buildings | - | 2,099 | 2,099 |
Machinery | - | 852.71 | 777.99 |